Issue link: https://viewer.e-digitaledition.com/i/695025
Sources: National Cancer Institute, National Down Syndrome Society, Celiac Disease Foundation, National Institute of Diabetes and Digestive and Kidney Diseases Hypothyroidism affects 13 to 50 percent of adults with Down syndrome but only 4.6 percent of typical Americans age 12 and older. Acutemegakaryoblastic leukemia, a rare form of AML that accounts for 10 percent of childhood AML cases, is 500 times more likely to develop in children with Down syndrome. However, kids with Down syndrome are much more likely to survive the disease than typical children. Celiac disease, an autoimmune disorder that occurs when a person is unable to digest the wheat proteingluten,affects up to 16 percent of individuals with Down syndrome but only 1 percent of typical people. Kirk Hansen, Ph.D. Brianne Bettcher, Ph.D. Steven Maier, Ph.D. Christopher Por ter, M.D. Kelly Sullivan, Ph.D. CONTINUED ON PAGE 10 INCREASING EVIDENCE SUGGESTS that malfunction of the immune system in people with Down syndrome may be linked to their higher risk for leukemia, autoimmune disorders, and cognitive impairment. Five of 11 researchers funded by the 2016 Crnic Grand Challenge Grants are studying diverse aspects of the immune system in people with Down syndrome but taking markedly different approaches — from testing drugs that affect inflammation in the brain using mouse models to defining the repertoire of immune cells in the blood of people with Down syndrome. A controlled immune reaction is part of a healthy, natural response to microbes and injuries, but in some circumstances, the immune system views healthy cells as invaders and attacks them, leading to harmful autoimmunity. Several lines of evidence indicate that the immune system is hyperactive in people with Down syndrome, which would explain the increased risk of autoimmune disorders. "One cannot overemphasize the importance of the diversity of these investigations," said Tom Blumenthal, Ph.D., Executive Director of the Crnic Institute. "The potential findings on the horizon from this research, made possible by funding from Global, may play a role in significant discoveries leading to enhanced quality of life for those with Down syndrome and benefits for the typical population, as well." FIVE APPROACHES TO STUDYING THE IMMUNE SYSTEM Brianne Bettcher, Ph.D., Assistant Professor of Neurosurgery at the University of Colorado (CU) Anschutz Medical Campus, will study the relationship among brain function, structure, and markers of immune activity in adults with Down syndrome, particularly those with early stage Alzheimer's disease. Kirk Hansen, Ph.D., Associate Professor of Biochemistry and Molecular Genetics at CU Anschutz Medical Campus, will investigate the metabolic changes that accompany chronic activation of the immune system, which could lead to novel therapeutic strategies. Steven Maier, Ph.D., Distinguished Professor of Psychology and Neurosciences at CU Boulder, will investigate whether immune modulation impacts cognition using a mouse model of Down syndrome. Christopher Porter, M.D., Associate Professor of Hematology, Oncology, and Bone Marrow Transplant in the Department of Pediatrics at CU Anschutz Medical Campus, plans to analyze how the extra copy of chromosome 21 impacts the number and function of diverse types of immune cells. His research interests focus on novel therapies for leukemia. GLOBALDOWNSYNDROME.ORG 9

